Innovating by leveraging our fully integrated ecosystem, to accelerate the creation of novel therapies that arm the immune system.
North Carolina
Joined February 2012
- Tweets192
- Following205
- Followers4.9K
- Likes110
NightHawk Biosciences retweeted
Today, we announced my administration's most significant economic development investment since I took office. Scorpion will bring 500 new, high-paying jobs to Manhattan and inject $650 million in business investment into the KS economy. This is a game-changer for our state.
NightHawk Biosciences retweeted
Please join $HTBX on Tuesday at 10:30 AM EST for a planned livestream event highlighting new developments. Don’t miss this event:
vimeo.com/event/2027558/fc6d…
NightHawk Biosciences retweeted
Welcome Scorpion! Our university, our community, and our PEOPLE are excited to be your partners, your hometown, and your neighbors. Welcome to Manhappiness and K-State. A very special place! @KState @MHKChamber @HeatBiologics @KansasCommerce
Please join $HTBX on Tuesday at 10:30 AM EST for a planned livestream event highlighting new developments. Don’t miss this event:
vimeo.com/event/2027558/fc6d…
Pleased to welcome Greg Burel, former Director of the Strategic National Stockpile (SNS), to $HBTX’s Biothreat Advisory Board: bit.ly/3umcO8d
Heat Biologics is pleased to announce that we will move our listing to the @NYSE American, where we expect to begin trading on Monday, February 14 under the same $HTBX ticker symbol. For details, see our announcement: bit.ly/3B2CmtR
Join Bioprocess Online (@BioProcessOL) tomorrow, Tuesday Feb 1 at 11 a.m. ET, for a live interactive panel discussion with CEO @jeffwolfheatbio and two other biotech execs to discuss pandemic preparedness. Register here: bit.ly/3z8qAgw
Promising new preclinical data on our PTX-35 has been published in the American Journal of Transplantation (@amjtransplant). Data supports further study in inflammatory disease and transplantation tolerance. Learn more: bit.ly/3FobPb5
NightHawk Biosciences retweeted
Great time-lapse of our Scorpion clean room pods being installed in our San Antonio facility. The pods are #MadeinAmerica, as is all of our Scorpion manufacturing. Looking forward to a ribbon-cutting of our first manufacturing facility in the coming months. We're getting there!
$HTBX is proud to deepen its commitment to #biosecurity with the acquisition of Elusys Therapeutics and their approved countermeasure for inhalation #anthrax. More here: bit.ly/3slfMuc
“RapidVax really presents a new paradigm in responding to biothreats,” said $HTBX CEO Jeff Wolf, in an interview with Homeland Preparedness News (@homelandprep). Learn more on how Heat is preparing to leverage RapidVax against emerging biological threats: bit.ly/3DCC2BV
Today, $HTBX unveiled its RapidVax® cellular vaccine platform, which is being designed to enable an accelerated response to a wide variety of infectious agents by providing a flexible “plug-and-play” vaccine platform. To learn more, click here: bit.ly/3G1pRzW
We're pleased to welcome Paul Tebbey, Ph.D. as Senior Vice President of Product Development and Portfolio Strategy. Paul's experience in pharma & biotech includes several approved vaccines and therapies in immune-mediated disorders and infectious diseases: bit.ly/3ledwkh
David Lasseter, a member of our biothreat advisory board, spoke with @tteminWFED on The Federal Drive podcast about the need to prepare the U.S. for biological threats and future pandemics, and Heat's ongoing efforts to do so. Listen here: bit.ly/2WLwaGY @FederalNewsNet
$HTBX's new biothreat advisory board is actively focused on improving U.S. pandemic preparedness. Read more in @biospace: bit.ly/3BmmBwX
Today, $HTBX unveiled Skunkworx Bio, a new subsidiary focused on rapid drug discovery and validation. Skunkworx utilizes proprietary libraries of “Pocket Biologics” used to identify proteins that bind to druggable targets. Read more on the launch here: bit.ly/3mz2dnU
Heat CEO @jeffwolfheatbio spoke to @TriBizTech at the @TriangleBIZJrnl about new "Blackhawk" biothreat subsidiary: “Covid-19 is relatively mild compared to potential biothreats on the horizon.” Full article here: bit.ly/3zcF91X
Join us in welcoming former U.S. Senator Mark Pryor as the newest member of our biothreat advisory board: bit.ly/3mpFsmh
Proud to announce 2 members of our new biothreat advisory board: Fmr. Asst. Sec. of Defense for Nuclear, Chemical & Biological Defense Programs Andrew C. Weber, & chemical & biological weapons expert Gregory D. Koblentz, Ph.D: bit.ly/2UxxkVx @AndyWeberNCB @gregkoblentz
